Boston Scientific
419 hedge funds and large institutions have $14.1B invested in Boston Scientific in 2013 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 135 increasing their positions, 176 reducing their positions, and 31 closing their positions.
54% more call options, than puts
Call options by funds: $42.6M | Put options by funds: $27.7M
39% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 31
29% more capital invested
Capital invested by funds: $11B → $14.1B (+$3.19B)
2% more funds holding
Funds holding: 410 → 419 (+9)
2.19% more ownership
Funds ownership: 87.61% → 89.79% (+2.2%)
0% more funds holding in top 10
Funds holding in top 10: 12 → 12 (0)
23% less repeat investments, than reductions
Existing positions increased: 135 | Existing positions reduced: 176
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$523M |
| 2 |
BG
Bollard Group
Boston,
Massachusetts
|
+$154M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$108M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$102M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$83.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$311M |
| 2 |
Dodge & Cox
San Francisco,
California
|
-$245M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$123M |
| 4 |
FC
Fairpointe Capital
Chicago,
Illinois
|
-$93.9M |
| 5 |
Renaissance Technologies
New York
|
-$59.9M |
BSX Hedge Fund Activity: Q3 2013 in Review
419 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2013, worth a combined $14.1B — up 29% from $11B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new BSX positions and 31 closed out — a net gain of 12 holders — while 135 added to existing stakes and 176 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $523M. The largest seller was Wellington Management Group, cutting an estimated $311M.
- 419 institutional investors held Boston Scientific (BSX) as of Q3 2013, up from 410 in Q2 2013.
- Funds reported $14.1B of Boston Scientific stock for Q3 2013, up 29% quarter-over-quarter.
- 43 funds opened new Boston Scientific positions in Q3 2013 and 31 closed out, a net change of +12 holders.
- The largest Boston Scientific buyer in Q3 2013 was Fidelity Investments, an estimated $523M added.
- The largest Boston Scientific seller in Q3 2013 was Wellington Management Group, an estimated $311M sold.
Based on aggregated 13F filings for Q3 2013.